AMN vs. ABBV
Compare and contrast key facts about AMN Healthcare Services, Inc. (AMN) and AbbVie Inc. (ABBV).
Performance
AMN vs. ABBV - Performance Comparison
Loading graphics...
AMN vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMN AMN Healthcare Services, Inc. | 15.48% | -34.11% | -68.06% | -27.17% | -15.95% | 79.24% | 9.53% | 9.97% | 15.05% | 28.09% |
ABBV AbbVie Inc. | -7.86% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Fundamentals
AMN:
$704.94M
ABBV:
$370.48B
AMN:
-$2.48
ABBV:
$2.38
AMN:
0.26
ABBV:
6.05
AMN:
$2.73B
ABBV:
$61.16B
AMN:
$774.06M
ABBV:
$44.85B
AMN:
$63.90M
ABBV:
$28.29B
Returns By Period
In the year-to-date period, AMN achieves a 15.48% return, which is significantly higher than ABBV's -7.86% return. Over the past 10 years, AMN has underperformed ABBV with an annualized return of -6.20%, while ABBV has yielded a comparatively higher 18.22% annualized return.
AMN
- 1D
- -1.94%
- 1M
- -13.29%
- YTD
- 15.48%
- 6M
- -6.91%
- 1Y
- -22.06%
- 3Y*
- -39.71%
- 5Y*
- -24.42%
- 10Y*
- -6.20%
ABBV
- 1D
- -2.86%
- 1M
- -10.70%
- YTD
- -7.86%
- 6M
- -10.37%
- 1Y
- 5.19%
- 3Y*
- 13.21%
- 5Y*
- 18.43%
- 10Y*
- 18.22%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMN vs. ABBV — Risk / Return Rank
AMN
ABBV
AMN vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AMN Healthcare Services, Inc. (AMN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AMN | ABBV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.37 | 0.19 | -0.56 |
Sortino ratioReturn per unit of downside risk | -0.20 | 0.44 | -0.63 |
Omega ratioGain probability vs. loss probability | 0.98 | 1.06 | -0.08 |
Calmar ratioReturn relative to maximum drawdown | -0.67 | 0.28 | -0.95 |
Martin ratioReturn relative to average drawdown | -1.22 | 0.62 | -1.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AMN | ABBV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.37 | 0.19 | -0.56 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.49 | 0.82 | -1.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.14 | 0.71 | -0.85 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.02 | 0.72 | -0.74 |
Correlation
The correlation between AMN and ABBV is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AMN vs. ABBV - Dividend Comparison
AMN has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.18%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMN AMN Healthcare Services, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.18% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
Drawdowns
AMN vs. ABBV - Drawdown Comparison
The maximum AMN drawdown since its inception was -89.99%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for AMN and ABBV.
Loading graphics...
Drawdown Indicators
| AMN | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.99% | -45.09% | -44.90% |
Max Drawdown (1Y)Largest decline over 1 year | -34.18% | -14.86% | -19.32% |
Max Drawdown (5Y)Largest decline over 5 years | -88.11% | -21.92% | -66.19% |
Max Drawdown (10Y)Largest decline over 10 years | -88.11% | -45.09% | -43.02% |
Current DrawdownCurrent decline from peak | -85.67% | -13.23% | -72.44% |
Average DrawdownAverage peak-to-trough decline | -45.46% | -10.70% | -34.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.36% | 7.44% | +11.92% |
Volatility
AMN vs. ABBV - Volatility Comparison
AMN Healthcare Services, Inc. (AMN) has a higher volatility of 11.92% compared to AbbVie Inc. (ABBV) at 7.85%. This indicates that AMN's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AMN | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.92% | 7.85% | +4.07% |
Volatility (6M)Calculated over the trailing 6-month period | 46.73% | 18.09% | +28.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 59.93% | 27.18% | +32.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.63% | 22.65% | +26.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.43% | 25.71% | +19.72% |
Financials
AMN vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between AMN Healthcare Services, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMN vs. ABBV - Profitability Comparison
AMN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AMN Healthcare Services, Inc. reported a gross profit of 232.51M and revenue of 748.23M. Therefore, the gross margin over that period was 31.1%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.
AMN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AMN Healthcare Services, Inc. reported an operating income of 47.30M and revenue of 748.23M, resulting in an operating margin of 6.3%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.
AMN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AMN Healthcare Services, Inc. reported a net income of -7.70M and revenue of 748.23M, resulting in a net margin of -1.0%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.